PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+4.58%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$663M
AUM Growth
+$34.3M
(+5.5%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
47.41%
Holding
224
New
41
Increased
20
Reduced
31
Closed
32
Top Buys
| 1 |
United Therapeutics
UTHR
|
$13.5M |
| 2 |
Cytokinetics
CYTK
|
$12.6M |
| 3 |
Illumina
ILMN
|
$10.5M |
| 4 |
ICU Medical
ICUI
|
$9.41M |
| 5 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
$7.52M |
Top Sells
| 1 |
Biogen
BIIB
|
$25.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 3 |
Pulmonx
LUNG
|
$9.13M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$9.01M |
| 5 |
Evolent Health
EVH
|
$7.06M |
Sector Composition
| 1 | Healthcare | 90.69% |
| 2 | Industrials | 0.83% |
| 3 | Materials | 0.39% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Apyx Medical
APYX
$71.9M
| $6.77M | 0.39% |
1,508,062
+184,759
| +14% | +$830K |
|
27
AbbVie
ABBV
$374B
| $6.71M | 0.39% |
+50,000
| New | +$6.71M |
|
28
Schrodinger
SDGR
$1.42B
| $6.5M | 0.38% |
260,000
+210,000
| +420% | +$5.25M |
|
|
SLGC
29
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $6.42M | 0.37% |
2,213,200
+90,080
| +4% | +$261K |
|
30
AtriCure
ATRC
$1.73B
| $5.98M | 0.35% |
152,834
+46,219
| +43% | +$1.81M |
|
31
iRhythm Technologies
IRTC
$5.67B
| $5.95M | 0.34% |
47,521
-2,479
| -5% | -$311K |
|
32
Milestone Pharmaceuticals
MIST
$151M
| $5.48M | 0.32% |
596,531
-390,880
| -40% | -$3.59M |
|
33
Tenet Healthcare
THC
$16.5B
| $5.16M | 0.3% |
+100,000
| New | +$5.16M |
|
34
Transmedics
TMDX
$3.65B
| $5.01M | 0.29% |
+120,000
| New | +$5.01M |
|
|
BCYC
35
Bicycle Therapeutics
BCYC
$492M
| $4.96M | 0.29% |
213,121
+30,000
| +16% | +$698K |
|
|
RCM
36
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.83M | 0.28% |
260,400
+10,668
| +4% | +$198K |
|
|
TSVT
37
DELISTED
2seventy bio
TSVT
| $4.73M | 0.27% |
+325,000
| New | +$4.73M |
|
38
Cooper Companies
COO
$13.3B
| $4.68M | 0.27% |
70,992
-59,008
| -45% | -$3.89M |
|
39
Privia Health
PRVA
$2.85B
| $4.6M | 0.27% |
135,000
-43,255
| -24% | -$1.47M |
|
40
DexCom
DXCM
$30.9B
| $4.57M | 0.26% |
+56,700
| New | +$4.57M |
|
41
Avita Medical
RCEL
$116M
| $4.53M | 0.26% |
858,951
+117,076
| +16% | +$617K |
|
42
TELA Bio
TELA
$65.4M
| $4.43M | 0.26% |
520,079
-35,544
| -6% | -$303K |
|
43
Terns Pharmaceuticals
TERN
$651M
| $4.29M | 0.25% |
+728,600
| New | +$4.29M |
|
44
Bioventus
BVS
$471M
| $4.11M | 0.24% |
586,696
-12,384
| -2% | -$86.7K |
|
45
Gossamer Bio
GOSS
$587M
| $4.1M | 0.24% |
341,878
+261,000
| +323% | +$3.13M |
|
46
Sanofi
SNY
$122B
| $3.71M | 0.21% |
+97,684
| New | +$3.71M |
|
47
Intuitive Surgical
ISRG
$158B
| $3.7M | 0.21% |
+19,732
| New | +$3.7M |
|
48
Masimo
MASI
$7.43B
| $3.64M | 0.21% |
+25,800
| New | +$3.64M |
|
49
Tandem Diabetes Care
TNDM
$834M
| $3.59M | 0.21% |
+75,000
| New | +$3.59M |
|
50
Agilon Health
AGL
$497M
| $3.51M | 0.2% |
150,000
-86,100
| -36% | -$2.02M |
|